Navigation Links
InterMune Presents Research on ITMN-191 in Hepatitis C at EASL,Annual Meeting

tors and interferons, and discovering important insights into possible treatment regimens for chronic hepatitis C," said Lawrence M. Blatt, Ph.D., Chief Scientific Officer of InterMune. "We anticipate that treatment regimens will involve multiple agents, and we are hopeful that these combinations will lead to improved, sustained virologic responses for patients who are in need of more optimal therapies."

The third presentation concerned NS3 sequence variations in HCV replicons after exposure to ITMN-191 at clinically relevant concentrations. The NS3 sequence was found to undergo dynamic changes when exposed to increasing concentrations of ITMN-191. As was seen in previous work, substitution at position 168 of NS3 appears to be fundamental to resistance but alone is not sufficient for HCV replicon persistence at all ITMN-191 concentrations achieved in the liver of animal species following oral dosing. This suggests that the genetic barrier to resistance in patients following clinical dosing of ITMN-191 may be significant dependent upon human liver exposure.

InterMune currently is conducting a Phase 1a clinical study of ITMN-191 for the treatment of chronic HCV. Preclinical toxicology and pharmacokinetic studies in multiple species demonstrated that ITMN-191 has a favorable toxicology profile, significant liver exposure, high in vitro potency and specificity, and an advantageous cross-resistance profile, including considerable effectiveness against variants of the NS3/4A protease that are resistant to other HCV protease inhibitors currently in development. The preclinical pharmacokinetic results support the exploration of twice-daily oral dosing. InterMune and Roche have a collaboration agreement for the research, development and commercialization of ITMN-191 (referred to as R7227 within the Roche research and development programs) and second-generation HCV protease inhibitor compounds.

According to the Centers for Disease Control and Prevention (
'"/>




Page: 1 2 3 4

Related medicine technology :

1. InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive Disease Week Meeting
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
4. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
5. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
6. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
7. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
8. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
9. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
10. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
11. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: InterMune Presents Research ITMN Hepatitis EASL Annual Meeting
(Date:7/30/2015)... Takeda Pharmaceutical Company Limited ("Takeda") today announced ... post-marketing commitment and submissions of data to regulatory ... Cancer Risk Characterization Study , a large (n= ... four European countries, for pioglitazone containing medicines, including ... of follow-up. Findings demonstrate that there is no ...
(Date:7/30/2015)... -- Global ENT (Ear, Nose, And ... 23.01 million in 2022, according to a new study ... population, increasing prevalence of ear, nose, and throat related ... target customer base are expected serve this market as ... to estimates published by the WHO, 15% of adult ...
(Date:7/30/2015)... , July 30, 2015 ... market ? Which areas are going to grow at ... shows you potential revenues to 2025, assessing data, trends, ... report provides 176 tables, charts, and graphs. Discover ... future market prospects. Our new study lets you assess ...
Breaking Medicine Technology:Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 2Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 3Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 4Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 5Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 6ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 2ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 3ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 4ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 5Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 5Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 6
... INDIANAPOLIS, Sept. 7 BioStorage Technologies Inc., a ... logistics and sample management for the biotechnology and ... Hager to global director of supply chain. ... will spearhead BioStorage Technologies, supply chain activities for ...
... that a new market research report is ... The Top 10 Orthopedic Device Companies: Financial ... http://www.reportlinker.com/p0289100/The-Top-10-Orthopedic-Device-Companies-Financial-performance-research-activities-and-growth-strategies.html ... competitive and has reached maturity, as demonstrated ...
Cached Medicine Technology:BioStorage Technologies Appoints New Global Director of Supply Chain 2Reportlinker Adds The Top 10 Orthopedic Device Companies: Financial performance, research activities, and growth strategies 2Reportlinker Adds The Top 10 Orthopedic Device Companies: Financial performance, research activities, and growth strategies 3Reportlinker Adds The Top 10 Orthopedic Device Companies: Financial performance, research activities, and growth strategies 4Reportlinker Adds The Top 10 Orthopedic Device Companies: Financial performance, research activities, and growth strategies 5Reportlinker Adds The Top 10 Orthopedic Device Companies: Financial performance, research activities, and growth strategies 6Reportlinker Adds The Top 10 Orthopedic Device Companies: Financial performance, research activities, and growth strategies 7Reportlinker Adds The Top 10 Orthopedic Device Companies: Financial performance, research activities, and growth strategies 8
(Date:7/31/2015)... ... July 31, 2015 , ... Intellitec Solutions ... recent implementation of Microsoft Dynamics GP for a senior living facility in Maine. ... supporting senior living communities in 16 states. This further expansion was again a ...
(Date:7/30/2015)... Tucson, AZ (PRWEB) , ... July 31, 2015 , ... ... getaways may seem impossible or out-of-reach. The questions race through your mind: What happens ... is a storm? You feel overwhelmed and cancel your plans. , But not taking ...
(Date:7/30/2015)... (PRWEB) , ... July 31, 2015 , ... On July ... meeting in Manatee county to discuss plausible solutions for controlling the heroin outbreak. Ultimately ... event of an overdose is largely perpetuating the heroin crisis in North Florida. The ...
(Date:7/30/2015)... Texas (PRWEB) , ... July 30, 2015 , ... ... Path Institute (C-Path), and TransCelerate BioPharma, Inc. are pleased to announce that data ... have been published for use on the CDISC website . These three ...
(Date:7/30/2015)... ... July 30, 2015 , ... Women's dating coach Simone ... It's for women interested in improving their love lives using specific "lines" designed ... launched to the public early this morning, has drawn praise from several dating ...
Breaking Medicine News(10 mins):Health News:Intellitec Solutions Expands Long term Care ERP Offerings to Maine 2Health News:Aging Life Care Association™ Experts Offer Tips for Caregivers in Need of Vacation Time 2Health News:Aging Life Care Association™ Experts Offer Tips for Caregivers in Need of Vacation Time 3Health News:Manatee County’s Opioid Task Force Calls for More Funding and Face to Face Counseling After Overdose 2Health News:Manatee County’s Opioid Task Force Calls for More Funding and Face to Face Counseling After Overdose 3Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 2Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 3Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 4Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 5Health News:Lovetraction Lines - Review Examining Simone Myers' New Online Course Released 2
... Conference Call at 10 a.m. EST, January 28, 2008, ... IMA ) and Matria Healthcare, Inc. (Nasdaq: ... definitive agreement pursuant to,which Inverness will acquire all outstanding ... payable $6.50 in cash plus $32.50 in,convertible preferred stock ...
... Surgeons, Jolie, Kidman, Anderson, Loren, Bundchen, Pitt, and ... hear it every day, "Oh, I wish I,could look ... I,d do anything.",With increasing availability of aesthetic plastic surgery, ... some of these wishes are coming true. But do ...
... the first and only co-formulated protease ... use in children with HIV, ABBOTT PARK, Ill., ... that the European Committee for Medicinal Products for Human ... (EMEA),has issued a positive opinion recommending approval of a ...
... Shazaaam! LLC, an integrated,marketing communications agency headquartered ... and Marketing Communications Agency of,Record for Enuresis ... social marketing, proactive and reactive,blogging, traditional and ... and visibility among its target market., ...
... Germany, January 28 Gerresheimer,AG has quickly completed ... Dusseldorf manufacturer of glass and plastic products for ... it continues its global expansion, on 21 December ... Valencia) and Argentina (Buenos,Aires) specialises in pharma containers ...
... The Department of Defense has commissioned a nine-month study ... Medical Center to determine whether a new drug based ... of acute radiation injury following radiation exposure. The new ... was greater than 5,000 times more effective at reducing ...
Cached Medicine News:Health News:Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc. 2Health News:Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc. 3Health News:Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc. 4Health News:Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc. 5Health News:Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc. 6Health News:Celebrity Influences on Plastic Surgery 2Health News:Celebrity Influences on Plastic Surgery 3Health News:Celebrity Influences on Plastic Surgery 4Health News:Abbott's Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower-Strength Tablet for Pediatric Use Receives Positive Opinion from EMEA 2Health News:Abbott's Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower-Strength Tablet for Pediatric Use Receives Positive Opinion from EMEA 3Health News:Abbott's Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower-Strength Tablet for Pediatric Use Receives Positive Opinion from EMEA 4Health News:Abbott's Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower-Strength Tablet for Pediatric Use Receives Positive Opinion from EMEA 5Health News:Abbott's Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower-Strength Tablet for Pediatric Use Receives Positive Opinion from EMEA 6Health News:Abbott's Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower-Strength Tablet for Pediatric Use Receives Positive Opinion from EMEA 7Health News:Abbott's Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower-Strength Tablet for Pediatric Use Receives Positive Opinion from EMEA 8Health News:Shazaaam! Named PR Agency of Record for Enuresis Treatment Center 2Health News:Feds fund study of drug that may prevent radiation injury 2
This modular benchtop fume hood ventilates and purifies chemical fumes, allowing safe indoor release of exhaust. Bonded charcoal filters remove most organic contaminants. Options include final HEPA f...
... proof polypropylene exhaust hoods are designed to ... and draw a stream of air across ... the operator. Other sizes and types of ... double-slot are available on special order in ...
... This fume hood is the ... but includes a flat internal ... the shell. The baffle slopes ... air flow to sweep the ...
... polypropylene exhaust hoods are designed to rest ... draw a stream of air across the ... operator. Other sizes and types of hoods ... are available on special order in materials ...
Medicine Products: